Takeda Pharmaceutical (TAK) Buildings (2017 - 2019)

Takeda Pharmaceutical has reported Buildings for 3 years, with the latest figure at $1.1 billion in Q1 2019.

• On a quarterly basis, Buildings changed N/A year-over-year to $1.1 billion in Q1 2019; TTM through Mar 2019 was $1.1 billion, a N/A change from a year earlier, with the FY2019 full-year figure at $1.1 billion, changed N/A from the prior year.
• Buildings was $1.1 billion for Q1 2019 at Takeda Pharmaceutical, down from $2.9 billion in the prior quarter.
• The five-year high for Buildings was $2.9 billion in Q4 2018, with the low at $1.1 billion in Q1 2019.
• Average Buildings over 3 years is $2.0 billion, with a median of $1.9 billion recorded in 2017.
• The largest YoY upside for Buildings was 51.69% in 2018 against a maximum downside of 51.69% in 2018.
• Over 3 years, Buildings stood at $1.9 billion in 2017, then jumped by 51.69% to $2.9 billion in 2018, then tumbled by 61.19% to $1.1 billion in 2019.
• The last three Buildings figures came in at $1.1 billion (Q1 2019), $2.9 billion (Q4 2018), and $1.9 billion (Q4 2017), per Business Quant data.